Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NV-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2021-03-11 | 2021-04-29 | 135561 |
| NV-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2025-10-01 | 2025-10-01 | 268159 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT | Resolved | 2022-03-04 | 2022-03-24 | 156070 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2022-08-18 | 2024-06-17 | 166969 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 20MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2022-08-18 | 2024-06-13 | 166972 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2022-08-18 | 2024-06-13 | 166975 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2024-10-11 | 2024-11-08 | 240046 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2024-10-17 | 2025-01-30 | 240525 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2024-11-28 | 2025-05-30 | 244081 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 20MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2025-01-09 | 2025-11-06 | 247309 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2025-07-29 | 2025-08-29 | 263746 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2025-09-19 | 2025-11-13 | 267502 |
| ONDANSETRON INJECTION | 2MG | SOLUTION | Actual shortage | 2017-03-13 | 2017-10-05 | 1746 |
| ONDANSETRON INJECTION | 2MG | SOLUTION | Actual shortage | 2017-03-13 | 2017-10-05 | 1754 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-06-18 | 2019-08-06 | 86905 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-06-18 | 2019-07-16 | 86908 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-06-27 | 2019-08-21 | 87684 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-09-12 | 2019-11-22 | 93650 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-09-26 | 2019-11-14 | 94840 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2020-02-21 | 2020-05-08 | 106955 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |